1. Home
  2. RJET vs FTRE Comparison

RJET vs FTRE Comparison

Compare RJET & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RJET

Republic Airways Holdings Inc.

N/A

Current Price

$23.55

Market Cap

930.0M

Sector

N/A

ML Signal

N/A

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$13.30

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RJET
FTRE
Founded
1982
1996
Country
United States
United States
Employees
8400
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.0M
829.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
RJET
FTRE
Price
$23.55
$13.30
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$14.06
AVG Volume (30 Days)
115.1K
1.5M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.09
P/E Ratio
$0.21
N/A
Revenue Growth
N/A
1.00
52 Week Low
$15.37
$3.97
52 Week High
$23.88
$18.67

Technical Indicators

Market Signals
Indicator
RJET
FTRE
Relative Strength Index (RSI) 62.69 55.18
Support Level $16.65 $8.85
Resistance Level $23.88 $18.26
Average True Range (ATR) 1.79 0.78
MACD 0.10 -0.23
Stochastic Oscillator 90.70 9.69

Price Performance

Historical Comparison
RJET
FTRE

About RJET Republic Airways Holdings Inc.

Republic Airways Holdings Inc is a regional airline mainly in North America. The company provides scheduled passenger service through its mainline partnerships with American Airlines, Delta Air Lines, and United Airlines. Republic offers scheduled passenger service on several daily flights to various cities in the United States, Canada, Mexico, and the Caribbean. It exclusively operates the dual-class Embraer E170/175 family of aircraft, and provides its services under the American Eagle, Delta Connection, or United Express brands. The company is organized and operates as one operating and reportable segment: regional airline services.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: